237 related articles for article (PubMed ID: 1376397)
21. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
22. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
24. [Antineoplastic effects of interferons].
Shimoyama M
Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
[No Abstract] [Full Text] [Related]
25. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
Spaccarelli N; Rook AH
Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.
Costa da Cunha CS; Lebbe C; Rybojad M; Agbalika F; Ferchal F; Rabian C; Vignon-Pennamen MD; Calvo F; Morel P
Arch Dermatol; 1996 Mar; 132(3):285-90. PubMed ID: 8607632
[TBL] [Abstract][Full Text] [Related]
27. Interferon treatment of renal cell carcinoma. Current status and future prospects.
Krown SE
Cancer; 1987 Feb; 59(3 Suppl):647-51. PubMed ID: 10822464
[TBL] [Abstract][Full Text] [Related]
28. [Interferons and interferon therapy].
Strander H
Nord Med; 1992; 107(3):70-1. PubMed ID: 1372403
[No Abstract] [Full Text] [Related]
29. The interferons. Mechanisms of action and clinical applications.
Baron S; Tyring SK; Fleischmann WR; Coppenhaver DH; Niesel DW; Klimpel GR; Stanton GJ; Hughes TK
JAMA; 1991 Sep; 266(10):1375-83. PubMed ID: 1715409
[TBL] [Abstract][Full Text] [Related]
30. Perspectives of cytokine treatment in malignant skin tumors.
Garbe C
Recent Results Cancer Res; 1995; 139():349-69. PubMed ID: 7597303
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled trial of systemically administered interferon-alpha, -beta, or -gamma in combination with cryotherapy for the treatment of condyloma acuminatum.
Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Pappas P; Holloway M; Corey L; Barnum G; Dunne A
J Infect Dis; 1995 May; 171(5):1081-9. PubMed ID: 7538546
[TBL] [Abstract][Full Text] [Related]
32. Chronic hepatitis B and C. What is the status of drug therapy?
Wright TL
Postgrad Med; 1992 Sep; 92(4):75-82. PubMed ID: 1382288
[TBL] [Abstract][Full Text] [Related]
33. Interferons in dermatology.
Stadler R; Mayer-da-Silva A; Bratzke B; Garbe C; Orfanos C
J Am Acad Dermatol; 1989 Apr; 20(4):650-6. PubMed ID: 2497154
[TBL] [Abstract][Full Text] [Related]
34. Interferons in HIV and related diseases.
Lane HC
AIDS; 1994 Sep; 8 Suppl 3():S19-23. PubMed ID: 7840912
[TBL] [Abstract][Full Text] [Related]
35. Interferon: current and future clinical uses in infectious disease practice.
Main J; Handley J
Int J STD AIDS; 1992; 3(1):4-9. PubMed ID: 1543767
[No Abstract] [Full Text] [Related]
36. Clinical use of biologic response modifiers in cancer treatment: an overview. Part I. The interferons.
Balmer CM
DICP; 1990; 24(7-8):761-8. PubMed ID: 1695795
[TBL] [Abstract][Full Text] [Related]
37. Cancer immunotherapy: the interferon-alpha experience.
Kirkwood J
Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
[TBL] [Abstract][Full Text] [Related]
38. [Interferon-alpha-induced psoriasis vulgaris].
Wölfer LU; Goerdt S; Schröder K; Zouboulis CC; Orfanos CE
Hautarzt; 1996 Feb; 47(2):124-8. PubMed ID: 8868456
[TBL] [Abstract][Full Text] [Related]
39. Interferons in dermatology. Present-day standard.
Stadler R
Dermatol Clin; 1998 Apr; 16(2):377-98. PubMed ID: 9589211
[TBL] [Abstract][Full Text] [Related]
40. Intralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin application.
Boot JM; Blog FB; Stolz E
Genitourin Med; 1989 Jan; 65(1):50-3. PubMed ID: 2921053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
